Radiogenomics and radiomics in liver cancers

Aman Saini, Ilana Breen, Yash Pershad, Sailendra Naidu, Grace Knuttinen, Sadeer Alzubaidi, Rahul Sheth, Hassan Albadawi, Malia Kuo, Rahmi Oklu

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Radiogenomics is a computational discipline that identifies correlations between cross-sectional imaging features and tissue-based molecular data. These imaging phenotypic correlations can then potentially be used to longitudinally and non-invasively predict a tumor’s molecular profile. A different, but related field termed radiomics examines the extraction of quantitative data from imaging data and the subsequent combination of these data with clinical information in an attempt to provide prognostic information and guide clinical decision making. Together, these fields represent the evolution of biomedical imaging from a descriptive, qualitative specialty to a predictive, quantitative discipline. It is anticipated that radiomics and radiogenomics will not only identify pathologic processes, but also unveil their underlying pathophysiological mechanisms through clinical imaging alone. Here, we review recent studies on radiogenomics and radiomics in liver cancers, including hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and metastases to the liver.

Original languageEnglish (US)
Article number4
JournalDiagnostics
Volume9
Issue number1
DOIs
StatePublished - Mar 1 2019

Fingerprint

Cholangiocarcinoma
Pathologic Processes
Liver Neoplasms
Liver
Hepatocellular Carcinoma
Neoplasm Metastasis
Imaging techniques
Neoplasms
Medical imaging
Tumors
Decision making
Tissue
Clinical Decision-Making

Keywords

  • Hepatocellular carcinoma
  • Intrahepatic cholangiocarcinoma
  • Liver metastasis
  • Radiogenomics
  • Radiomics

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Radiogenomics and radiomics in liver cancers. / Saini, Aman; Breen, Ilana; Pershad, Yash; Naidu, Sailendra; Knuttinen, Grace; Alzubaidi, Sadeer; Sheth, Rahul; Albadawi, Hassan; Kuo, Malia; Oklu, Rahmi.

In: Diagnostics, Vol. 9, No. 1, 4, 01.03.2019.

Research output: Contribution to journalReview article

Saini, Aman ; Breen, Ilana ; Pershad, Yash ; Naidu, Sailendra ; Knuttinen, Grace ; Alzubaidi, Sadeer ; Sheth, Rahul ; Albadawi, Hassan ; Kuo, Malia ; Oklu, Rahmi. / Radiogenomics and radiomics in liver cancers. In: Diagnostics. 2019 ; Vol. 9, No. 1.
@article{10caa4066148427eb9405e22b32eec7e,
title = "Radiogenomics and radiomics in liver cancers",
abstract = "Radiogenomics is a computational discipline that identifies correlations between cross-sectional imaging features and tissue-based molecular data. These imaging phenotypic correlations can then potentially be used to longitudinally and non-invasively predict a tumor’s molecular profile. A different, but related field termed radiomics examines the extraction of quantitative data from imaging data and the subsequent combination of these data with clinical information in an attempt to provide prognostic information and guide clinical decision making. Together, these fields represent the evolution of biomedical imaging from a descriptive, qualitative specialty to a predictive, quantitative discipline. It is anticipated that radiomics and radiogenomics will not only identify pathologic processes, but also unveil their underlying pathophysiological mechanisms through clinical imaging alone. Here, we review recent studies on radiogenomics and radiomics in liver cancers, including hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and metastases to the liver.",
keywords = "Hepatocellular carcinoma, Intrahepatic cholangiocarcinoma, Liver metastasis, Radiogenomics, Radiomics",
author = "Aman Saini and Ilana Breen and Yash Pershad and Sailendra Naidu and Grace Knuttinen and Sadeer Alzubaidi and Rahul Sheth and Hassan Albadawi and Malia Kuo and Rahmi Oklu",
year = "2019",
month = "3",
day = "1",
doi = "10.3390/diagnostics9010004",
language = "English (US)",
volume = "9",
journal = "Diagnostics",
issn = "2075-4418",
publisher = "MDPI AG",
number = "1",

}

TY - JOUR

T1 - Radiogenomics and radiomics in liver cancers

AU - Saini, Aman

AU - Breen, Ilana

AU - Pershad, Yash

AU - Naidu, Sailendra

AU - Knuttinen, Grace

AU - Alzubaidi, Sadeer

AU - Sheth, Rahul

AU - Albadawi, Hassan

AU - Kuo, Malia

AU - Oklu, Rahmi

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Radiogenomics is a computational discipline that identifies correlations between cross-sectional imaging features and tissue-based molecular data. These imaging phenotypic correlations can then potentially be used to longitudinally and non-invasively predict a tumor’s molecular profile. A different, but related field termed radiomics examines the extraction of quantitative data from imaging data and the subsequent combination of these data with clinical information in an attempt to provide prognostic information and guide clinical decision making. Together, these fields represent the evolution of biomedical imaging from a descriptive, qualitative specialty to a predictive, quantitative discipline. It is anticipated that radiomics and radiogenomics will not only identify pathologic processes, but also unveil their underlying pathophysiological mechanisms through clinical imaging alone. Here, we review recent studies on radiogenomics and radiomics in liver cancers, including hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and metastases to the liver.

AB - Radiogenomics is a computational discipline that identifies correlations between cross-sectional imaging features and tissue-based molecular data. These imaging phenotypic correlations can then potentially be used to longitudinally and non-invasively predict a tumor’s molecular profile. A different, but related field termed radiomics examines the extraction of quantitative data from imaging data and the subsequent combination of these data with clinical information in an attempt to provide prognostic information and guide clinical decision making. Together, these fields represent the evolution of biomedical imaging from a descriptive, qualitative specialty to a predictive, quantitative discipline. It is anticipated that radiomics and radiogenomics will not only identify pathologic processes, but also unveil their underlying pathophysiological mechanisms through clinical imaging alone. Here, we review recent studies on radiogenomics and radiomics in liver cancers, including hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and metastases to the liver.

KW - Hepatocellular carcinoma

KW - Intrahepatic cholangiocarcinoma

KW - Liver metastasis

KW - Radiogenomics

KW - Radiomics

UR - http://www.scopus.com/inward/record.url?scp=85064588284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064588284&partnerID=8YFLogxK

U2 - 10.3390/diagnostics9010004

DO - 10.3390/diagnostics9010004

M3 - Review article

AN - SCOPUS:85064588284

VL - 9

JO - Diagnostics

JF - Diagnostics

SN - 2075-4418

IS - 1

M1 - 4

ER -